• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Campbell Alliance forms suite of services for product launches

Campbell Alliance forms suite of services for product launches

February 2, 2015
CenterWatch Staff

Campbell Alliance, the consulting arm of inVentiv Health, has formed the Campbell Alliance Launch Suite, an integrated offering designed to bring products to market primed for success.

As pharmaceutical companies face patent expiries and shrinking pipelines, product launches are a critical component for growth. With over 400 launches on the horizon in the next three years, it will be crucial for pharmaceutical companies to capture the full value from each launch.

More than a decade ago, Campbell Alliance pioneered the Launch Playbook, and claims this strategic planning process and project management tool has resulted in clients experiencing an average of 45% improvement in time to launch when compared to launches of similar drugs that went to market without using the Launch Playbook. Campbell Alliance built on this best-in-class offering to create a comprehensive launch suite for clients preparing to commercialize a new product in the current complex, crowded and competitive healthcare marketplace.

"Biopharmaceutical companies know that to successfully launch a product in the new healthcare environment, they need to redefine how they commercialize assets," said Michael Griffith, executive vice president of inVentiv Health and president of the commercial division. "The Campbell Alliance Suite is one offering of our contract commercial organization (CCO), an outsourcing model that realizes efficiencies to accelerate performance and delivery. We have seen that enhanced commercialization leads to enhanced value."

The suite pairs strategic insights and tools, informed by planning launches for nearly 60% of new U.S. molecular entities and more than 500 global launch engagements. The scalable offering allows clients to tap into experts who have managed launches across a wide range of product types, geographic markets and therapeutic areas. The suite, which is centered on a proprietary launch framework, includes:

• Launch Strategy: Insights and business-driven global and market-level launch strategy, with a focus on therapeutic areas, as well as product categories (e.g., rare diseases, biosimilars and small footprint launches).

• Launch Planning: Leveraging the Launch Playbook process and upgraded project management platform, Campbell guides clients in developing global launch plans, assessing launch readiness and developing risk mitigation plans. The web-based Launch Playbook tool features a new dashboard section for improved project management, risk tracking and enhanced reporting.

• Launch Management: Seamless launch execution, utilizing the right tools and methodologies to develop meaningful key performance indicators and diagnose progress.

• Launch Excellence: Institutionalization of Launch Excellence within an organization by establishing the foundational launch elements for developing strategy, planning and management.

"With the strategic recommendations from our launch and subject matter experts, we help clients design and assess their overall launch strategy, track and gauge their progress to launch and achieve critical outcomes," said Rohit Sood, head of Global Launch Excellence at Campbell Alliance. "Launches are a key milestone in the success of an asset, and we recognize that the scope of each launch varies by asset and market. We fully adapt our approach and solutions to each client's business objectives and organizational footprint."

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing